Elixirgen Scientific

Elixirgen Scientific is a global leader in regenerative medicine and biotechnology, headquartered in the Science + Technology Park at the Johns Hopkins Medical Campus in Baltimore, MD. Our mission is to advance science and medicine with fast, functional, and scalable induced pluripotent stem cell (iPSC) differentiation products and services. Our state-of-the-art, transcription-factor-based technology allows you to overcome the high cost and inefficiencies associated with lengthy cell differentiation periods. We empower research institutions, pharmaceutical organizations, and biomedical enterprises worldwide, even those with no previous iPSC experience, by increasing access to relevant cells for modeling human biology and accelerating the path to...

Stem cell differentiation,human ips cells,stem cells,induced pluripotent stem cells,in vitro differentiation,ipscs,neuronal differentiation,gabaergic neurons,dopaminergic neurons,cholinergic neurons,ips cells,sensory neurons,astrocytes,and excitatory neurons

Elixirgen scientific operates in the Biotechnology research industry.

Elixirgen scientific's revenue is 11m - 100m

Elixirgen scientific has 11 - 50 employees.